SER-109
Seres Therapeutics
['seres therap']
seres therapeutics and nestl health science present results from ecospor iv phase 3 study of vowst , a microbiota-based oral therapeutic for prevention of recurrence of c. difficile infection, at the digestive disease week (ddw) annual meeting 
Pharmaceutical News - Direct Information